The Indiana Myeloma Registry

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Lead sponsor: Indiana University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Attaya Suvannasankha, MD

CONTACT

317-274-0843 asuvanna@iu.edu

Nisha George, MD

CONTACT

(317) 274-6635 nishgeor@iu.edu

Trial snapshot

StatusRECRUITING

Phase—

Enrollment2,500

Start dateJun 2018

Last updatedNov 10, 2025

Condition

Plasma Cell Dyscrasias

Locations shown

Indiana University Simon Cancer Center

Indianapolis, Indiana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions